[Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice XIANYANG, China, April 23, 2018 – Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) (“the Company”), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China, announced today that on EX-99.1 2 e]